The company reported $5.92 billion in revenues for the quarter, driven by growth across its four business segments.
Agena has an ongoing partnership with Guangzhou-based DaRui to develop MassArray-based diagnostics for cancer and inherited diseases for the Chinese market.
The company reported $853 million in total revenues for the quarter, driven by growth across its sequencing and microarray products.
Palmetto GBA's decision that large syndromic MDx panels may not always be necessary prompted GenePOC's decision to further target smaller panels.
A case-control GWAS of individuals of African descent led to four chromosome 6 SNPs with apparent ties to bleeding risk associated with warfarin anticoagulants.
AWS joins Google Cloud in supporting STRIDES, a nascent NIH program aimed at reducing barriers to large-scale biomedical data analysis via cloud computing.
The novel technology uses DNA-barcoded antibodies to enable single-cell RNA sequencing platforms to detect and quantify protein expression.
The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.
Vox reports on inequities in genetic research and efforts to address them.
In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.